Case report: Long-term mood response to repeat dose intramuscular ketamine in a depressed patient with advanced cancer

Journal of Palliative Medicine

Volumn 16, Issue 7, 2013, Pages 719-720

  Zanicotti, Claudia Grott ^a   Perez, David ^b   Glue, Paul ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

KETAMINE;

ADULT; ADVANCED CANCER; CASE REPORT; DELIRIUM; DIZZINESS; DRUG TOLERABILITY; DSM-IV; FEMALE; HUMAN; INTESTINE OBSTRUCTION; LETTER; MAJOR DEPRESSION; MONTGOMERY ASBERG DEPRESSION RATING SCALE; MOOD; OVARY CANCER; RELAPSE;

ADULT; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; KETAMINE; OVARIAN NEOPLASMS; TREATMENT OUTCOME;

EID: 84880467266     PISSN: 10966218     EISSN: 15577740     Source Type: Journal    
DOI: 10.1089/jpm.2013.0057     Document Type: Letter

References (5)

1. Zanicotti CG, Perez D, Glue P: Mood and pain responses to repeat dose intramuscular ketamine in a depressed patient with advanced cancer. J Palliat Med 2012;15:400-403
2. Montgomery SA, Asberg M: A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382-389
3. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. (text revision). Washington, DC: APA, 2000
4. Anderson IM, Ferrier IN, Baldwin RC et al.: Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines. J Psychopharmacol 2008;22: 343-396
5. Glue P, Donovan MR, Kolluri S, Emir B: Meta-analysis of relapse prevention antidepressant trials in depressive disorders. Aust N Z J Psychiatry 2010;44:697-705